2020-2027 Analysis and Review Sutherlandia Extracts Market

Sutherlandia Extracts Market

Sutherlandia Extracts Market By Clinical Application (Immunomodulatory Agent, Cancer and Others), By Distribution Channel (Supermarket, Retail Stores and E-commerce) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020 – 2027

15-07-2020 REP-HC-5135 40 Tables 110 pages Format

The sutherlandia extracts market was valued at USD 326.9 Mn by 2019. Rising prevalence of retroviral infection primarily drives the sutherlandia extracts market growth. Additionally, the growing incidence of cancer among young adults throughout the globe further accentuates the market growth.

Sutherlandia Extracts Market

Sutherlandia frutescens is also known as balloon pea, cancer bush, etc is a traditional herbal drug indigenous in the South Africa region. Traditionally it has been used for the treatment of HIV/AIDS infection in the people belonging to the Africa region. It is a small orange-colored shrub that is aromatic with the bitter taste and has been in controversy regarding the claim of intellectual property rights regarding its medicinal use by major industrial and governmental stakeholders across the globe.

The major segments related to the sutherlandia extracts market are: 

By Clinical Application (2017–2027; US$ Mn)

Immunomodulatory Agent

Cancer

Others

By Distribution Channel (2017–2027; US$ Mn)

Supermarket

Retail Stores

E-commerce

Geography Segment (2017–2027; US$ Mn)

North America

U.S.
Canada

Europe

United Kingdom
Germany
Russia
France
Italy
Spain
Ukraine
Rest of Europe

Asia Pacific

China
Japan
Rest of Asia Pacific

Latin America (LATAM)

Brazil
Mexico
Rest of Latin America

Middle East and Africa (MEA)

GCC
Rest of MEA 

Justification for study?

  • The intention of the study is to give a comprehensive outlook of the global sutherlandia extracts market
  • The overall segmentation of the sutherlandia extracts market, by clinical application, distribution channel, and geography is minutely studied. immunomodulatory agent and supermarket are dominating the clinical application and distribution channel segments respectively
  • Rising prevalence of retroviral infections worldwide
  • Significant increase in the clinical trial investigation regarding the therapeutic efficacy of sutherlandia extract in the treatment of cancer further accentuates the market growth

Report gist?

  • The study of the global sutherlandia extracts market includes qualitative analysis of factors such as drivers, restraints, and opportunities
  • The report covers the qualitative and quantitative analysis of the overall market segmented on the basis of clinical application and distribution channel and categorization of the same at the geography level
  • This research report presents the analysis of each segment from 2017 to 2027 in which 2019 is considered as the base year. The compounded annual growth rate is calculated for the respective segments from 2020 to 2027

The study includes the profiles of major market players with a significant global and regional presence along with top company positioning. 

Significant customers?

  • This study is suitable for industry participants and stakeholders in the nutraceutical  manufacturers actively engaged in the production and marketing of sutherlandia extracts due to the rising prevalence of viral infections worldwide
  • The report will benefit dieticians engaged in the prescription of sutherlandia extract products to boost the immunity in the immunocompromised patients worldwide
  • Managers with financial institutions looking to publish recent and forecasted statistics pertaining to sutherlandia extracts market
  • Financial institutions, venture capitalist, analysts, investors, government organizations, policymakers, regulatory authorities, researchers, looking for insights into the market to determine future strategies 

Segment Analysis

The immunomodulatory agent is representing the largest market share in the clinical application segment for sutherlandia extracts market. As per the latest statistics provided by the World Health Organization (WHO), in 2019 approximately 38.0 million people were living with AIDS across the globe. Sutherlandia extract comprises of the active constituent L-canavanine which is an arginine analog that is reported to be exhibiting its pharmacodynamic effect against retroviral infection in human beings. Recent studies have reported the clinical application of sutherlandia extract in the treatment of autoimmune diseases by boosting innate immunity. Cancer will be highlighting comfortable market growth during the forecast period on account of the growing incidence of cancer among young adults throughout the globe. According to the latest information provided by the American Cancer Society (ACS), approximately 1 in 6 deaths globally is associated with cancer, making it the second leading cause of death worldwide.

The supermarket is currently spearheading the distribution channel segment for sutherlandia extracts market. The urban population prefers visiting supermarkets on weekends to purchase grocery and dietary supplements owing to the exposure to diverse product portfolio and the availability of attractive discounts on various purchases. Retail stores are still the most preferred shopping destination for dietary supplements for residents living in remote locations. E-commerce is expected to register exemplary market performance during the forecast period on account of the deep market penetration of high-speed internet services and access to smartphones to purchase various health foods at affordable prices.

North America is presently dominating the geography segment for sutherlandia extracts market. The rising prevalence of cancer primarily drives market growth in the region. As per the Center for Disease Control and Prevention (CDC), in 2020 approximately 1.8 million new cases were diagnosed in the United States. The existence of well-developed healthcare infrastructure and increasing public health awareness regarding the health benefits of sutherlandia extract further consolidates the market growth in the region. Europe is considered as the second-largest regional segment for sutherlandia extracts market on account of the growing incidence of viral infection in the region. The Asia Pacific is anticipated to be the fastest-growing regional segment for sutherlandia extracts market. Flourishing herbal drugs market and constant rise in the E-commerce segment together determine the market growth in the region.

Select License Type

$4,600
$6,600
$13,200

Safe and Secure SSL Encrypted

Have a Question?

We will help you find what you are looking for.

Call 1-518-730-1560

Contact sales

How can we help you?

Get in touch with us or find an office closest to you.